Assertion: thalidomide | /r/CapableOf | double the five-year survival rate
Facets:
value: from 29 percent
type: OTHER
value: in patients with recurring myeloma
type: OTHER
Source sentences:
text: Another watershed trial found that thalidomide doubled the five-year survival rate in patients with recurring myeloma, an incurable blood cancer, from 29 percent to 58 percent.